Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics. With a passion to succeed, we give hope to cancer patients and thei...
Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics. With a passion to succeed, we give hope to cancer patients and their families by the development and commercialization of new oncology therapeutics. Our experienced cancer drug development organization is committed to advancing our lead drug candidate, QINPREZO™ (vosaroxin), through clinical trials. QINPREZO is a first-in-class anti-cancer quinolone derivative, or AQD — a class of compounds that has not been used previously for the treatment of cancer. The commitment to advancing oncology treatment and patient care is paramount at Sunesis, and it drives every aspect of our business. • Our work—pursuing the best possible translational and clinical science to ensure that we deliver meaningful medicines to our patients • Our workplace—creating a stimulating, teamwork-oriented environment for the employees involved in this important work • Our community—supporting the larger oncology community and the philanthropic organizations that help patients and caregivers.